- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.59 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NXL: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide(Covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: Y.175, V.211, T.237, H.243
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.175, A:Y.175, A:T.237
- Salt bridges: A:H.243
SO4.3: 11 residues within 4Å:- Chain A: T.197, G.198, P.199, R.201, E.261
- Chain B: K.76, P.81, K.88, P.92
- Ligands: NXL.1, NA.12
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:G.198, B:P.92
- Water bridges: A:R.201, B:K.76
- Salt bridges: A:R.201, B:K.76, B:K.88
SO4.4: 1 residues within 4Å:- Chain A: K.182
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:K.182
SO4.5: 4 residues within 4Å:- Chain A: N.127, K.128, N.131
- Ligands: NA.15
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.131
- Water bridges: A:N.127, A:K.128, A:K.128, A:K.128
- Salt bridges: A:K.128
SO4.27: 4 residues within 4Å:- Chain B: Y.175, V.211, T.237, H.243
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Y.175, B:Y.175
- Salt bridges: B:H.243
SO4.28: 11 residues within 4Å:- Chain A: K.76, P.81, K.88, P.92
- Chain B: T.197, G.198, P.199, R.201, E.261
- Ligands: NXL.26, NA.37
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrogen bonds: B:G.198, A:P.92
- Water bridges: B:R.201, A:K.76
- Salt bridges: B:R.201, A:K.76, A:K.88
SO4.29: 1 residues within 4Å:- Chain B: K.182
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:K.182
SO4.30: 4 residues within 4Å:- Chain B: N.127, K.128, N.131
- Ligands: NA.40
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:N.131
- Water bridges: B:N.127, B:K.128, B:K.128, B:K.128
- Salt bridges: B:K.128
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.6: 6 residues within 4Å:- Chain A: F.174, N.177, E.178, I.179, L.180, Y.185
Ligand excluded by PLIPCL.7: 5 residues within 4Å:- Chain A: T.83, W.84, N.113, H.151
- Ligands: NXL.1
Ligand excluded by PLIPCL.31: 6 residues within 4Å:- Chain B: F.174, N.177, E.178, I.179, L.180, Y.185
Ligand excluded by PLIPCL.32: 5 residues within 4Å:- Chain B: T.83, W.84, N.113, H.151
- Ligands: NXL.26
Ligand excluded by PLIP- 34 x NA: SODIUM ION(Non-functional Binders)
NA.8: 4 residues within 4Å:- Chain A: L.98, S.99, E.102
- Ligands: NA.14
Ligand excluded by PLIPNA.9: 3 residues within 4Å:- Chain A: K.105, S.106, H.110
Ligand excluded by PLIPNA.10: 5 residues within 4Å:- Chain A: E.39, K.40, T.163, D.165
- Ligands: NA.11
Ligand excluded by PLIPNA.11: 5 residues within 4Å:- Chain A: N.140, T.163, D.165, A.166
- Ligands: NA.10
Ligand excluded by PLIPNA.12: 6 residues within 4Å:- Chain A: G.198, P.199, K.200, E.261
- Chain B: K.76
- Ligands: SO4.3
Ligand excluded by PLIPNA.13: 7 residues within 4Å:- Chain A: T.195, T.196, T.197, P.199, K.203, H.214
- Ligands: NA.19
Ligand excluded by PLIPNA.14: 3 residues within 4Å:- Chain A: K.71, E.97
- Ligands: NA.8
Ligand excluded by PLIPNA.15: 5 residues within 4Å:- Chain A: G.124, G.125, N.127, K.128
- Ligands: SO4.5
Ligand excluded by PLIPNA.16: 5 residues within 4Å:- Chain A: M.150, A.153, W.154, V.156, Q.157
Ligand excluded by PLIPNA.17: 5 residues within 4Å:- Chain A: G.28, I.29, E.30, D.31, H.243
Ligand excluded by PLIPNA.18: 6 residues within 4Å:- Chain A: L.79, K.88, Y.91, P.92, N.93, G.94
Ligand excluded by PLIPNA.19: 7 residues within 4Å:- Chain A: M.192, I.193, T.195, K.203, V.212, H.214
- Ligands: NA.13
Ligand excluded by PLIPNA.20: 5 residues within 4Å:- Chain A: L.15, A.20, K.21, V.22, N.38
Ligand excluded by PLIPNA.21: 5 residues within 4Å:- Chain A: S.134, V.138, K.139, N.140, I.141
Ligand excluded by PLIPNA.22: 6 residues within 4Å:- Chain A: T.221, G.225, T.227, S.253, S.254, E.255
Ligand excluded by PLIPNA.23: 6 residues within 4Å:- Chain A: S.218, S.219, T.227, A.229, T.230
- Chain B: N.82
Ligand excluded by PLIPNA.24: 4 residues within 4Å:- Chain A: T.126, N.127, I.143, K.144
Ligand excluded by PLIPNA.33: 4 residues within 4Å:- Chain B: L.98, S.99, E.102
- Ligands: NA.39
Ligand excluded by PLIPNA.34: 3 residues within 4Å:- Chain B: K.105, S.106, H.110
Ligand excluded by PLIPNA.35: 5 residues within 4Å:- Chain B: E.39, K.40, T.163, D.165
- Ligands: NA.36
Ligand excluded by PLIPNA.36: 5 residues within 4Å:- Chain B: N.140, T.163, D.165, A.166
- Ligands: NA.35
Ligand excluded by PLIPNA.37: 6 residues within 4Å:- Chain A: K.76
- Chain B: G.198, P.199, K.200, E.261
- Ligands: SO4.28
Ligand excluded by PLIPNA.38: 7 residues within 4Å:- Chain B: T.195, T.196, T.197, P.199, K.203, H.214
- Ligands: NA.44
Ligand excluded by PLIPNA.39: 3 residues within 4Å:- Chain B: K.71, E.97
- Ligands: NA.33
Ligand excluded by PLIPNA.40: 5 residues within 4Å:- Chain B: G.124, G.125, N.127, K.128
- Ligands: SO4.30
Ligand excluded by PLIPNA.41: 5 residues within 4Å:- Chain B: M.150, A.153, W.154, V.156, Q.157
Ligand excluded by PLIPNA.42: 5 residues within 4Å:- Chain B: G.28, I.29, E.30, D.31, H.243
Ligand excluded by PLIPNA.43: 6 residues within 4Å:- Chain B: L.79, K.88, Y.91, P.92, N.93, G.94
Ligand excluded by PLIPNA.44: 7 residues within 4Å:- Chain B: M.192, I.193, T.195, K.203, V.212, H.214
- Ligands: NA.38
Ligand excluded by PLIPNA.45: 5 residues within 4Å:- Chain B: L.15, A.20, K.21, V.22, N.38
Ligand excluded by PLIPNA.46: 5 residues within 4Å:- Chain B: S.134, V.138, K.139, N.140, I.141
Ligand excluded by PLIPNA.47: 6 residues within 4Å:- Chain B: T.221, G.225, T.227, S.253, S.254, E.255
Ligand excluded by PLIPNA.48: 6 residues within 4Å:- Chain A: N.82
- Chain B: S.218, S.219, T.227, A.229, T.230
Ligand excluded by PLIPNA.49: 4 residues within 4Å:- Chain B: T.126, N.127, I.143, K.144
Ligand excluded by PLIP- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.25: 9 residues within 4Å:- Chain A: Q.46, M.150, H.151, W.154, Q.157, S.219, D.220
- Chain B: N.82
- Ligands: NXL.1
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.46, A:H.151, A:Q.157, A:D.220
- Water bridges: A:A.153
GOL.50: 9 residues within 4Å:- Chain A: N.82
- Chain B: Q.46, M.150, H.151, W.154, Q.157, S.219, D.220
- Ligands: NXL.26
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:Q.46, B:Q.157, B:D.220
- Water bridges: B:H.151, B:A.153
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, W. et al., Structural Insights into the TLA-3 Extended-Spectrum beta-Lactamase and Its Inhibition by Avibactam and OP0595. Antimicrob. Agents Chemother. (2017)
- Release Date
- 2017-07-12
- Peptides
- Beta-lactamase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.59 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NXL: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide(Covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 34 x NA: SODIUM ION(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, W. et al., Structural Insights into the TLA-3 Extended-Spectrum beta-Lactamase and Its Inhibition by Avibactam and OP0595. Antimicrob. Agents Chemother. (2017)
- Release Date
- 2017-07-12
- Peptides
- Beta-lactamase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A